MIRA Pharmaceuticals, Inc. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Chromadex Corp.

Nature's Sunshine Products, Inc.

USANA Health Sciences, Inc.

ProPhase Labs, Inc.

Upexi, Inc.

Natural Alternatives International, Inc.

LifeVantage Corp.

Revolution Medicines, Inc.

Cidara Therapeutics, Inc.

MIRA Pharmaceuticals, Inc.

Bright Green Corp.

Why is MIRA Pharmaceuticals, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is MIRA Pharmaceuticals, Inc. for you?

High Risk, Medium Return

Absolute

Risk Adjusted

Volatility

MIRA Pharmaceuticals, Inc.

-3.85%

0.27

81.06%

S&P 500

14.9%

0.77

19.29%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

0.00%

EBIT Growth (5y)

0.00%

EBIT to Interest (avg)

-2.64

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.93

Sales to Capital Employed (avg)

405.57

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

11.31%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

6.71

EV to EBIT

-5.38

EV to EBITDA

-5.38

EV to Capital Employed

43.13

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

-801.83%

ROE (Latest)

-104.02%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

OPERATING PROFIT(Q)

Highest at USD -1.32 MM

PRE-TAX PROFIT(Q)

Highest at USD -1.31 MM

-13What is not working for the Company

NET PROFIT(Q)

Lowest at USD -22.87 MM

EPS(Q)

Lowest at USD -1.18

Here's what is working for MIRA Pharmaceuticals, Inc.

Operating Profit

Highest at USD -1.32 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (USD MM)

Pre-Tax Profit

Highest at USD -1.31 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Raw Material Cost

Fallen by 0% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for MIRA Pharmaceuticals, Inc.

Net Profit

At USD -22.87 MM has Fallen at -1,018.98%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (USD MM)

Net Profit

Lowest at USD -22.87 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (USD MM)

EPS

Lowest at USD -1.18

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (USD)